Clinical trial
Safety and Efficacy of Venetoclax in Idiopathic Pulmonary Fibrosis
NCT05976217 is registered in ClinicalTrials.gov with University of Alabama at Birmingham as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Efficacy of Venetoclax in Idiopathic Pulmonary Fibrosis
- Lead sponsor
- University of Alabama at Birmingham
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- October 1, 2023
- Completion date
- March 20, 2024
- Enrollment
- 3 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.